Hemoxymed, Molecular Geriatrics deal

HMYD, which is developing its Hemoxygenation technology to increase tissue oxygenation, plans to merge with Molecular Geriatrics, a developer of an Alzheimer's disease (AD) diagnostics and cancer ther...